OCUL Neutral Sentiment
OCULAR THERAPEUTIX, INC. Amendment No. 3 to 2019 Inducement Stock Incentive Plan Ocular Therapeutix, Inc's 2019 Inducement Stock Incentive Plan (the " Plan "), pursuant to Section 11(d) thereof, is hereby amended as set
Tuesday, April 16, 2024 BiopharmaWatch Research 1 min read Key Takeaway: Ocular Therapeutix, Inc. has announced an amendment to its 2019 Inducement Stock Incentive Plan, increasing the number of shares available for awards to 4,804,000. This change was made in accordance with Section 11(d) of the Plan. Apart from this specific amendment, all other terms of the Plan remain unchanged and effective. The Board of Directors adopted this amendment on April 16.
Full Press Release Details
Amendment No. 3 to 2019 Inducement Stock
Ocular Therapeutix, Inc's 2019 Inducement
Stock Incentive Plan (the "Plan"), pursuant to Section 11(d) thereof, is hereby amended as set forth below.
"Subject to adjustment under Section 9, Awards
may be made under the Plan for up to 4,804,000 shares of common stock, $0.0001 par value per share, of the Company (the "Common
Except as set forth above, all other terms of
the Plan shall remain unchanged and in full force and effect.
Adopted by the Board of Directors: April 16,